You can help researchers imrprove public health by volunteering for NIAID clinical studies.
There are more than 150 different forms of primary immune deficiency diseases (PIDDs) and, though they affect only about 500,000 people in the United States, these diseases are chronic and debilitating. Since the 1980s NIAID-supported investigators have been examining the causes and complications of PIDDs to improve the lives of patients and families affected by these conditions.
NIAID aims to improve diagnosis, facilitate genetic counseling, and explore new treatments and preventions for PIDDs. It is home to a Primary Immune Deficiency Clinic, which provides diagnoses and disease management recommendations to those whose lives are touched by PIDDs.
Media Availability: Gene Therapy Shows Promise for Severe Combined Immunodeficiency—Oct. 8, 2014
Test Reliably Detects Inherited Immune Deficiency in Newborns—Aug. 20, 2014
Early Treatment Benefits Infants with Severe Combined Immunodeficiency—July 30, 2014
Media Availability: Genetic Defect May Confer Resistance to Certain Viral Infections—April 9, 2014
Targeted Therapy for WHIM Syndrome Shows Promise—Feb. 12, 2014
Study Provides Insights Into Diagnosis, Treatment of Rare Immune Disease—Jan. 7, 2014
News From NIAID-Supported Institutions
Last Updated October 08, 2014
Last Reviewed June 08, 2011